Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I study evaluates peptide vaccine including cancer/testis antigens

June 6, 2012

Clinical studies assess daily and twice-daily dosing of golvatinib

June 6, 2012

CalciMedica describes new class of immunomodulators

June 6, 2012

OMP-59R5 well tolerated in phase I study

June 6, 2012

New phase I data disclosed on KX2-391 in chemotherapy-naive bone-metastatic CRPC

June 6, 2012

First-in-human data presented on novel selective Notch pathway inhibitor

June 5, 2012

Clinical data show long-term effects of lebrikizumab and the role of periostin

June 5, 2012

Olodaterol shows efficacy in asthma trials

June 5, 2012

Preliminary phase I results presented on AZD-2014

June 5, 2012

Tyrosine-protein kinase SYK inhibitor has beneficial effects on asthma

June 5, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...